spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Fuse 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 30 Dec 2020
Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Final Results of BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 19 Nov 2020
SynOx Therapeutics raises €37M in Series A Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 Oct 2020
Minimally Invasive Ellipsys System Creates Fused, Permanent Vascular Access for Dialysis
Devices
 HSMN NewsFeed - 9 Oct 2020
Innovent and Lilly Jointly Announce the NMPA Granted Marketing Approval for HALPRYZA(R) (Rituximab Injection) in China
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Sep 2020
Obsidian Therapeutics Appoints Rob Ross, M.D., to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Aug 2020
Bausch & Lomb Launches Innovative Bausch & Lomb INFUSE(TM) Silicone Hydrogel (SiHy) Daily Disposable Contact Lenses
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 17 Jul 2020
Empirical Spine Completes Enrollment in Pivotal IDE Clinical Trial Studying LimiFlex in Degenerative Spondylolisthesis
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 15 Jul 2020
Paragon 28, Inc. is pleased to announce that the U.S. Food and Drug Administration has cleared the APEX 3D(TM) Total Ankle Replacement System
Devices Orthopaedic FDA
 HSMN NewsFeed - 30 Jun 2020
MedAlliance Gains CE Mark Approval for Coronary SELUTION SLR(TM) Sirolimus Drug Eluting Balloon
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 15 Jun 2020
Providence Medical Technology Announces First Patient Enrollment in the "FUSE" IDE Clinical Study
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 4 Jun 2020
Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round
Devices Oncology Venture Capital
 HSMN NewsFeed - 11 May 2020
Protalix BioTherapeutics Announces Positive Topline Results from the BRIDGE Phase III Open-Label, Switch-Over Clinical Trial Evaluating Pegunigalsidase Alfa for the Treatment of Fabry Disease
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2020
Novartis Kymriah(R) receives FDA Regenerative Medicine Advanced Therapy designation in follicular lymphoma
Biopharmaceuticals Regenerative Medicine Oncology FDA
 HSMN NewsFeed - 13 Apr 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2020
HEMA Biologics(TM) Announces FDA Approval of SEVENFACT(R) [coagulation factor VIIa (recombinant)-jncw] for Treatment and Control of Bleeding Episodes Occurring in Adult and Adolescent Hemophilia A and B Patients with Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Jan 2020
Crown Aesthetics Announces Addition Of ProGen PRP(TM) Advantage To ProGen PRP Portfolio
Devices Dermatology Product Launch
 HSMN NewsFeed - 18 Dec 2019
Conventus Orthopaedics Acquires Novel Intramedullary Technology from IntraFuse
Devices Orthopaedic Acquisitions
 HSMN NewsFeed - 27 Nov 2019
CTT Pharma Strengthens Board and Management Team
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 19 Nov 2019
Aruvant Appoints William Chou as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2019
Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Oct 2019
FDA Clears ORTHO(TM) Sera ID-MTS for Use on the ORTHO VISION(R) Analyzer
Diagnostics FDA
 HSMN NewsFeed - 3 Oct 2019
Turn Therapeutics(TM) Closes Series B Round to Fuel Lead Atopic Dermatitis Program Trial and Pipeline Expansion
Biopharmaceuticals Dermatology Venture Capital
 HSMN NewsFeed - 27 Sep 2019
Currax(TM) Pharmaceuticals LLC Announces the Acquisition of Nalpropion Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 25 Sep 2019
Body Vision Closing $20 Million in Series C Funding
Devices Diagnostics Venture Capital
 HSMN NewsFeed - 25 Jul 2019
Obsidian Therapeutics Announces Strengthening of Executive Leadership Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Jun 2019
European Radiology Profiles Seno Medical's Ground-Breaking Breast Cancer Diagnostic Technology
Devices Radiology
 HSMN NewsFeed - 29 Apr 2019
United Therapeutics Announces FDA Approval Of XPS(TM) And Steen Solution(TM) Used To Perform Centralized Ex-Vivo Lung Perfusion Services
Devices FDA
 HSMN NewsFeed - 16 Apr 2019
Cerebral Therapeutics Strengthens Clinical Development Leadership with Strategic Appointments
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 28 Mar 2019
Sciton Unveils New JOULE X Platfor(TM)m During ASLMS, Bringing Realtime Aesthetic Insights Into Your Hands
Devices Dermatology Product Launch
 HSMN NewsFeed - 8 Mar 2019
Cerebral Therapeutics Raises Series A Extension Financing to Advance Clinical-Stage Drug Device Combination Therapy to Phase 3 Readiness for Adult Refractory Epilepsy
Biopharmaceuticals Drug Delivery Venture Capital
 HSMN NewsFeed - 21 Feb 2019
Denovo Biopharma Announces New Hires for Positions of Chief Medical Officer of Hematology and Senior Vice President, Regulatory Affairs and Quality Assurance
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 7 Feb 2019
Marker Therapeutics Appoints Mythili Koneru, M.D., Ph.D. as Senior Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Jan 2019
Tragara Pharmaceuticals Appoints Scott Megaffin as Chief Executive Officer and Changes Name to Adastra Pharmaceuticals
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Nov 2018
Merck KGaA, Darmstadt, Germany, and Pfizer Provide Update on Avelumab in Platinum-Resistant/Refractory Ovarian Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Oct 2018
SI-BONE, Inc. Announces that NICE, the UK National Institute for Health and Care Excellence, Published Medical Technology Guidance Finding that the Evidence Supports Treatment of Sacroiliac Joint Pain with the iFuse Implant System(R)
Devices Orthopaedic Neurosurgery Regulatory
 HSMN NewsFeed - 1 Oct 2018
FDA Approves KYPROLIS(R) (carfilzomib) Once-Weekly 70 mg/m2 In Combination With Dexamethasone (Kd70) For Patients With Relapsed Or Refractory Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Aug 2018
SI-BONE, Inc. Announces France's National Healthcare System Establishes Exclusive Positive Coverage for the Triangular iFuse Implant System(R) for MIS SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 22 Aug 2018
MagVenture, Inc: FDA Clears 3-Minute, Non-Pharmaceutical Depression Treatment
Devices Neurology FDA
 HSMN NewsFeed - 8 Aug 2018
Janssen Submits U.S. & EU Regulatory Applications Seeking Approval of DARZALEX(R) (daratumumab) Split Dosing Regimen
Biopharmaceuticals Oncology FDA Regulatory
 HSMN NewsFeed - 8 Aug 2018
United Therapeutics Announces FREEDOM-EV Study Of Orenitram Meets Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 18 Jul 2018
Cook(R) Regentec Announces First U.S. Clinical Use of Advance(R) CS Coronary Sinus Infusion Catheter to Deliver a Therapeutic in Heart Failure Patients
Devices Drug Delivery Cardiology
 HSMN NewsFeed - 9 Jul 2018
Results of Phase III (PIX306) Trial Evaluating Progression-Free Survival of PIXUVRI(R) (pixantrone) Combined with Rituximab in Patients with Aggressive B-cell Non-Hodgkin Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jun 2018
FDA Authorizes FRESCA Medical To Market New Positive Airway Pressure Delivery System To Treat Sleep Apnea
Devices FDA
 HSMN NewsFeed - 21 Jun 2018
Mercator MedSystems Receives $11M in Series D Equity Financing Led by Shenzhen Salubris Pharmaceuticals Co.
Devices Interventional Venture Capital
 HSMN NewsFeed - 20 Jun 2018
Belmont Instrument, LLC Announces the Acquisition of MTRE Advanced Technologies Ltd.
Devices Mergers & Acquisitions
 HSMN NewsFeed - 18 Jun 2018
Mallinckrodt Reports Interim Findings Of H.P. Acthar(R) Gel (Repository Corticotropin Injection) Studies
Biopharmaceuticals
 HSMN NewsFeed - 12 Jun 2018
NuVasive Launches AttraX Scaffold Biologic And Reports First Clinical Use
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 7 Jun 2018
Centinel Spine Announces 510(k) Clearance of FLX(TM) Platform of 3D Printed All-Titanium Interbodies
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 31 May 2018
Curis Announces FDA Fast Track Designation for Fimepinostat Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 31 May 2018
Pivot Signs Option Agreement to Acquire Licensing Rights to Patented TriVair(TM) Nasal and Pulmonary Drug Delivery System For Its "RTIC" Ready-To-Infuse-Cannabis Powder
Devices Drug Delivery Licensing
 HSMN NewsFeed - 25 May 2018
Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA) for SUBLOCADE(TM) (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 17 May 2018
Statement from FDA Commissioner Scott Gottlieb, M.D., on new agency efforts to shine light on situations where drug makers may be pursuing gaming tactics to delay generic competition
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 May 2018
Refuge Biotechnologies Completes $25 Million Series B Financing, Appoints CSO to Advance the Development of Intelligent Cell Therapies in Oncology
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 26 Apr 2018
Endo to Acquire Somerset Therapeutics and Business of Affiliate Wintac Limited
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 10 Apr 2018
Wound Management Technologies Changes Name to WNDM Medical
Devices Surgery Wound Care
 HSMN NewsFeed - 26 Mar 2018
Bayer Announces Completion of Rolling Submission of New Drug Application in the U.S. for Larotrectinib for the Treatment of TRK Fusion Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 16 Mar 2018
FDA Approves Hizentra(R) (Immune Globulin Subcutaneous [Human] 20% Liquid) for the Treatment of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Biopharmaceuticals FDA
 HSMN NewsFeed - 12 Mar 2018
TAE Life Sciences to Develop Groundbreaking Therapy for Difficult-to-Treat Cancers, including Head, Neck and GBM; Announces $40 Million Series A Funding
Devices Oncology Venture Capital Personnel
 HSMN NewsFeed - 8 Feb 2018
N8 Medical Submits IDE for Breakthrough CeraShield(TM) Endotracheal Tube Device
Devices FDA
 HSMN NewsFeed - 5 Feb 2018
Tessa Therapeutics Announces Opening of Recruitment Sites Across the United States for its Phase III Nasopharyngeal Cancer Immunotherapy Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jan 2018
Novartis granted US FDA Priority Review for Kymriah(TM) (tisagenlecleucel), formerly CTL019, for adults with r/r DLBCL
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 3 Jan 2018
Denovo Biopharma Opens New R&D Center, Names Chief Medical Officer and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jan 2018
SI-BONE, Inc. Announces Blue Cross Blue Shield Association Raises Clinical Evidence Rating for MIS SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 25 Dec 2017
I-Mab Biopharma Signs Licensing Agreement for HyLeukin With Genexine
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 19 Dec 2017
Apellis Pharmaceuticals Expands Management Team, Appoints Timothy Sullivan Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Dec 2017
DARZALEX(R) (daratumumab) Combination Regimen Significantly Improved Outcomes for Newly Diagnosed Multiple Myeloma Patients who are Transplant Ineligible
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Nov 2017
Mitsubishi Tanabe Pharma America Announces Addition of RADICAVA(R) (edaravone) to U.S. Department of Veterans Affairs National Formulary
Biopharmaceuticals Neurology Reimbursement
 HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Vision Announces Series of Product Milestones and Launches Across Portfolio at American Academy of Ophthalmology 2017 Meeting
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 8 Nov 2017
Statement from FDA Commissioner Scott Gottlieb, M.D. on new steps to improve FDA review of shared Risk Evaluation and Mitigation Strategies to improve generic drug access
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 1 Nov 2017
IntraFuse Receives FDA 510(k) Clearance for FlexThread(TM) Fibula Pin System
Devices Orthopaedic FDA
 HSMN NewsFeed - 11 Oct 2017
DePuy Synthes Launches The First 3D Simulation Assisted Orthopaedic External Circular Fixation Device For Patients With Limb Deformity
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 9 Oct 2017
SI-BONE, Inc. Announces Utah's Public Employees Health Plan (PEHP) Establishes Coverage for the iFuse Procedure(TM) for Minimally Invasive SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 5 Sep 2017
ApiFix Signs Distribution Agreement in Canada; Completes First Cases in North America at IWK Health Centre Hospital, Halifax
Devices Orthopedic Neurosurgery Distribution
 HSMN NewsFeed - 30 Aug 2017
SonaCare Medical Delivers Compatability With bkFusion
Devices Product Launch
 HSMN NewsFeed - 29 Aug 2017
Leica FL560 achieves First FDA Clearance for cerebrovascular fluorescence with fluorescein
Devices Neurosurgery FDA
 HSMN NewsFeed - 8 Aug 2017
First FDA-Approved Treatment For ALS In 22 Years Now Available In U.S.
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 24 Jul 2017
eFFECTOR Therapeutics Completes $38.6 Million Series C Financing
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 17 Jul 2017
Medicenna Bolsters Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jul 2017
Neuro Spinal Hospital in Dubai to Acquire Accuray CyberKnife(R) and Radixact(TM) Systems
Devices Oncology Neurosurgery
 HSMN NewsFeed - 3 Jul 2017
BIOTRONIK US Announces Pivotal Trial Results of the Pulsar-18 Stent with 4-French Delivery System
Devices Interventional
 HSMN NewsFeed - 3 Jul 2017
New Analysis Reveals First-Line Treatment Data on SIR-Spheres(R) Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
Devices Oncology
 HSMN NewsFeed - 21 Jun 2017
410 Medical Receives Funding from Triangle Venture Alliance (TVA) - A Newly Formed Network Based on Angel Investors tied to Leading North Carolina Universities
Devices Venture Capital
 HSMN NewsFeed - 13 Jun 2017
SI-BONE, Inc. Announces FDA Clearance and Full U.S. Commercial Launch of the iFuse-3D(TM) Implant, a Patented, 3D-Printed Next Generation Member of the iFuse Implant System(R)
Devices Neurosurgery Orthopaedic Product Launch
 HSMN NewsFeed - 12 Jun 2017
SI-BONE, Inc. Announces Blue Cross and Blue Shield of Vermont Establishes Positive Coverage Policy for MIS Sacroiliac Joint Fusion
Devices Neurosurgery Orthopaedic Reimbursement
 HSMN NewsFeed - 7 Jun 2017
FDA Approves Hologic's Genius(TM) 3D Mammography(TM) Exam as the Only Mammogram Superior for Women with Dense Breasts*
Devices Radiology Oncology FDA
 HSMN NewsFeed - 8 May 2017
SI-BONE, Inc. Announces U.S. Military's TRICARE Now Covers MIS SI Joint Fusion
Devices Neurosurgery Orthopaedic Reimbursement
 HSMN NewsFeed - 26 Apr 2017
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Devices Interventional Drug Delivery
 HSMN NewsFeed - 24 Apr 2017
Seno Medical Instruments Appoints Ann Waterhouse as VP, Quality Assurance and Regulatory Affairs
Devices Oncology Personnel
 HSMN NewsFeed - 24 Apr 2017
SIR-Spheres(R) Y-90 Resin Microspheres Substantially Improves Quality of Survival in Primary Liver Cancer, New Study Against Standard Treatment Shows
Devices Oncology
 HSMN NewsFeed - 18 Apr 2017
Novartis CAR-T cell therapy CTL019 receives FDA Breakthrough Therapy designation for treatment of adult patients with r/r DLBCL
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Apr 2017
Zyga Releases 24-month CT Fusion and Clinical Results for SImmetry SI Joint Fusion with Decortication
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 7 Apr 2017
SI-BONE, Inc. Announces Published Guidance Recommendation for Minimally Invasive SI Joint Fusion from the National Institute for Health and Care Excellence (NICE)
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 3 Apr 2017
Atara Bio Expands Management Team, Appoints Joe Newell as Executive Vice President, Chief Technical Operations Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Mar 2017
Bovie Medical Receives 510K Clearance for Its Cool-Coag(TM) Generator and Open Handpiece
Devices Surgery FDA
 HSMN NewsFeed - 23 Mar 2017
410 Medical Closes $3.3 Million Initial Investment in Series A Financing
Devices Venture Capital
 HSMN NewsFeed - 15 Mar 2017
OmniGuide Surgical Announces Commercial Launch of VELOCITY(TM) High Performance CO2 Laser Fiber
Devices Surgery Product Launch
 HSMN NewsFeed - 14 Mar 2017
Teleflex (TFX) Announces 510(k) Clearance and Global Launch of Twin-Pass(R) Torque Dual Access Catheter
Devices Interventional Cardiology FDA Product Launch
 HSMN NewsFeed - 3 Mar 2017
Otsuka Pharmaceutical to Acquire Neurovance, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 28 Feb 2017
RenalGuard(R) Shown to Significantly Protect High-Risk Patients Undergoing Coronary Interventional Procedures from Acute Kidney Injury
Devices Interventional
 HSMN NewsFeed - 16 Feb 2017
Denovo Biopharma plans to launch a Global Phase 3 Trial of DB102 (Enzastaurin) in Diffuse Large B-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Feb 2017
410 Medical Announces Launch of LifeFlow(R) Rapid Infuser
Devices Product Launch
 HSMN NewsFeed - 18 Jan 2017
Seno Medical Instruments Appoints Steve Miller as SVP of Engineering
Devices Diagnostics Oncology Personnel
 HSMN NewsFeed - 23 Dec 2016
FUSE MEDICAL, INC. Announces $720,000 Capital Investment and New Leadership
Devices Orthopaedic Venture Capital
 HSMN NewsFeed - 5 Dec 2016
Novelion Therapeutics Subsidiary, Aegerion Pharmaceuticals, Enters Into Licensing Agreement With Amryt Pharma for LOJUXTA(R) (lomitapide)
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 22 Nov 2016
Boston Scientific Closes EndoChoice Acquisition
Devices Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 22 Nov 2016
DARZALEX(R) (daratumumab) Approved by U.S. FDA in Combination with Two Standard of Care Regimens for the Treatment of Patients with Multiple Myeloma Who Have Received At Least One Prior Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Nov 2016
Portola Pharmaceuticals Announces Three Phase 3 APEX Substudy Results Showing Further Benefits of Treating Acute Medically Ill Patients with Extended-Duration Betrixaban
Biopharmaceuticals
 HSMN NewsFeed - 4 Nov 2016
Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice
Devices Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 2 Nov 2016
CMS Publishes 2017 Final Hospital Outpatient and Ambulatory Surgical Center Payment Rule Increasing Outpatient Facility Reimbursement for MIS SI Joint Fusion Using SI-BONE's iFuse Implant System(R)
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 18 Oct 2016
Corbus Pharmaceuticals Receives Orphan Designation for Resunab for the Treatment of Cystic Fibrosis in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 7 Oct 2016
Boston Scientific Commences Cash Tender Offer For All Shares Of EndoChoice For $8.00 Per Share In Cash
Devices Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 6 Oct 2016
Kamada Announces Extension of GLASSIA(R) Supply and Distribution Agreement with Shire with Minimum $237 Million of Revenue for the Years 2017 to 2020
Biopharmaceuticals Distribution Licensing
 HSMN NewsFeed - 28 Sep 2016
Blue Cross Blue Shield of Nebraska Adopts Positive Coverage for Minimally Invasive Sacroiliac Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 27 Sep 2016
Boston Scientific to Acquire EndoChoice
Devices Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 15 Sep 2016
Teva Strengthens Injectables Portfolio with the Launch of an Authorized Generic of Cubicin(R) (Daptomycin for Injection) in the United States
Biopharmaceuticals Generics Product Launch
 HSMN NewsFeed - 12 Sep 2016
Karyopharm Appoints Humphrey A.R. Gardner MD, FCAP as Senior Vice President, Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 1 Sep 2016
Sunovion Pharmaceuticals to Acquire Cynapsus Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Aug 2016
Pfizer to Acquire Medivation
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 8 Aug 2016
Seno Medical Instruments Appoints Eric Davis as Chief Financial Officer
Devices Diagnostics Oncology Personnel
 HSMN NewsFeed - 28 Jul 2016
Caladrius Biosciences Receives FDA Fast Track Designation for CLBS03 to Treat Recent Onset Type 1 Diabetes
Biopharmaceuticals Endocrinology FDA
 HSMN NewsFeed - 28 Jul 2016
Journal of Urology Publishes Results of Exact Imaging's Initial PRI-MUS(TM) Protocol using High Resolution Micro-Ultrasound
Devices Urology Oncology
 HSMN NewsFeed - 18 Jul 2016
Genentech Provides Update on Phase III Study of Gazyva(R) in People With Previously Untreated Diffuse Large B-Cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 5 Jul 2016
SI-BONE, Inc. Appoints Tony Recupero Chief Commercial Officer
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 4 Jul 2016
European Commission Approves Extended Indication For Amgen's Kyprolis(R) (Carfilzomib) For The Treatment Of Relapsed Multiple Myeloma Patients
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Jun 2016
Savara Pharmaceuticals Acquires Serendex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Jun 2016
Geisinger Health Plan Announces Exclusive Coverage for the iFuse Implant System(R) for SI Joint Fusion
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 30 May 2016
FLIXABI(R), Biogen’s Infliximab Biosimilar Referencing Remicade(R), Approved in the European Union
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 May 2016
NuVasive Launches Next Generation Biologics Technology
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 20 May 2016
EndoChoice(R) Launches Third Generation Fuse(R) Full Spectrum Endoscopy(R) System
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 13 May 2016
Alprolix(R) (rFIXFc) approved in the EU for the treatment of haemophilia B
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 May 2016
FDA Clears Next-Generation Version of EndoGastric Solutions’ EsophyX(R) Device
Devices Gastroenterology FDA
 HSMN NewsFeed - 3 May 2016
SI-BONE, Inc. Surpasses 20,000 Surgeries With Triangular iFuse Implant System - Expands International Presence to 25 Countries
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 2 May 2016
EndoChoice(R) Announces William Enquist as New Chairman of the Board
Devices Gastroenterology Oncology Personnel
 HSMN NewsFeed - 31 Mar 2016
Humanwell Healthcare Group and PuraCap Pharmaceutical LLC to Acquire Epic Pharma, LLC
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Mar 2016
ProNAi Therapeutics Appoints Jeffrey H. Cooper and Tran Nguyen to its Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 15 Mar 2016
CardiacAssist Receives FDA 510(k) Clearance For Its TandemLung Oxygenator
Devices FDA
 HSMN NewsFeed - 15 Mar 2016
Orexigen and Takeda Jointly Announce Orexigen's Acquisition of All Rights to CONTRAVE(R) in the United States
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 14 Mar 2016
ProNAi Therapeutics Granted Orphan Drug Designation for PNT2258 for the Treatment of Diffuse Large B-Cell Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Mar 2016
Eigen USA and Hitachi Medical Systems Europe Switzerland Announce a Collaborative Agreement for Hitachi to Distribute the Artemis, Eigen's Robotic 3D Targeted Prostate Biopsy Device
Devices Oncology Distribution
 HSMN NewsFeed - 1 Mar 2016
Smith & Nephew Unveils its First 3D-Printed Titanium Hip Implant
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 23 Feb 2016
PTC Receives Refuse to File Letter from FDA for Translarna(TM) (ataluren)
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Feb 2016
Nipro Medical Corporation Launches the Cronus(TM) HP 0.035" OTW PTA Balloon Catheter in the United States
Devices Interventional Product Launch
 HSMN NewsFeed - 12 Feb 2016
SI-BONE, Inc. Announces Medicare Administrative Contractor National Government Services, Inc. Establishes Positive Coverage for MIS SI Joint Fusion Effective April 1st, 2016
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 11 Feb 2016
SI-BONE, Inc. Announces Two Economic Publications Showing iFuse Implant System is Cost Effective and Saves Money
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 8 Feb 2016
BMC Medical Co., Ltd Wins Patent Infringement Litigation Against ResMed
Devices Litigation
 HSMN NewsFeed - 4 Feb 2016
Sigmoid Pharma Announces Acquisition of Freund Pharmatec Ltd.
Biopharmaceuticals Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 2 Feb 2016
Telesta Therapeutics Receives Complete Response Letter from FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Feb 2016
Seno Medical Instruments Appoints Tom Umbel as Chief Executive Officer
Devices Diagnostics Oncology Personnel
 HSMN NewsFeed - 26 Jan 2016
RenalGuard Solutions(TM), Inc., Announces New European Clinical Trial to Evaluate the Long-Term Impact of RenalGuard Therapy(R) in Patients at High Risk for CI-AKI
Devices Interventional Cardiology
 HSMN NewsFeed - 20 Jan 2016
SI-BONE, Inc. Announces European Expansion with Formation of SI-BONE UK Ltd and Key Additions to Management Team
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 7 Jan 2016
EndoChoice(R) Enters Distribution Agreement with Chindex Medical Ltd. for China
Devices Distribution Gastroenterology
 HSMN NewsFeed - 3 Dec 2015
ProNAi Therapeutics Appoints Dr. Keith Anderson and Dr. Gregg Smith to its Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Nov 2015
NaviGate Cardiac Structures Inc. (“NCSI”) Reports First Patient Treated for Mitral Regurgitation (“MR”)
Devices Interventional Cardiology
 HSMN NewsFeed - 17 Nov 2015
KFx Announces Win at United States Supreme Court
Devices Orthopaedic Litigation
 HSMN NewsFeed - 9 Nov 2015
SI-BONE, Inc.(R) Announces iFuse Implant System(R) Receives Indication Cleared by the FDA that Includes Improved Pain, Patient Function and Quality of Life at 12-Months
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 9 Nov 2015
RedHill Biopharma and IntelGenx Announce First European Marketing Approval of RIZAPORT(TM) (RHB-103) for Migraines
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 2 Nov 2015
SI-BONE, Inc.(R) Announces Increased Medicare Payments for Hospital Outpatient and Physicians for MIS SIJ Fusion Surgery
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 2 Nov 2015
Shire to Acquire Dyax Corp, Expanding and Extending Industry-Leading Hereditary Angioedema (HAE) Portfolio
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2015
EndoGastric Solutions Announces New Sham-Controlled European Study Demonstrates Transoral Incisionless Fundoplication (TIF) Procedure as Effective Alternative for Daily PPI Treatment
Devices Gastroenterology
 HSMN NewsFeed - 14 Oct 2015
Benvenue Medical Announces Commercial Availability of Luna(R) 3D Interbody Fusion System, 2015 Spine Technology Award
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 15 Sep 2015
FDA Approves Octapharma’s NUWIQ for the Treatment of Adults and Children with Hemophilia
Biopharmaceuticals FDA
 HSMN NewsFeed - 1 Sep 2015
SI-BONE, Inc. Appoints Karen Licitra and Keith Valentine to its Board of Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 26 Aug 2015
ECM Medical Signs Agreement with Vertebral Technologies to Distribute Innovative Modular Spinal Implants for Greater China
Devices Orthopaedic Neurosurgery Distribution
 HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Jun 2015
Allergan to Acquire KYTHERA Biopharmaceuticals
Biopharmaceuticals Dermatology Mergers & Acquisitions
 HSMN NewsFeed - 11 May 2015
Cartiva, Inc. Closes $8.5 Million Financing
Devices Venture Capital Personnel
 HSMN NewsFeed - 19 Mar 2015
Daiichi Sankyo Signs Agreement With AstraZeneca To Co-Commercialize MOVANTIK In The US
Biopharmaceuticals
 HSMN NewsFeed - 12 Mar 2015
Volcano receives CE mark for iFR Scout Pullback software to help diagnose serial lesions and diffuse coronary disease
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 9 Mar 2015
SI-BONE, Inc. Announces Publication of INSITE, a Prospective Multicenter Randomized Controlled Trial using iFuse Triangular Implants
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 4 Feb 2015
Genentech’s Phase III Study of Gazyva(R) Showed Significant Benefit in Refractory Indolent Non-Hodgkin’s Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Feb 2015
FDA Approves New Dosing Option for CSL Behring's Hizentra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 15 Jan 2015
OCuSOFT(R) Introduces HypoChlor(TM) Spray and Gel (Hypochlorous Acid 0.02%) As Adjunct Therapy to its Lid Scrub(R) Family of Eyelid Cleansers
Biopharmaceuticals Ophthalmology Product Launch
 HSMN NewsFeed - 19 Dec 2014
Merck Begins Tender Offer to Acquire Cubist
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Dec 2014
Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Oct 2014
EndoGastric Solutions Announces Publication of Study Demonstrating Benefits of TIF Procedure in Controlling GERD Symptoms
Devices Gastroenterology
 HSMN NewsFeed - 17 Sep 2014
CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI(R)
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 16 Sep 2014
Venture Backed Catheter Connections Continues to Make False Statements, According to Ivera Medical
Devices
 HSMN NewsFeed - 10 Sep 2014
First Surgery in Japan Using InnFocus MicroShunt(TM)
Devices Ophthalmology
 HSMN NewsFeed - 25 Jul 2014
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA(R) (ibrutinib) for Treatment of Two Blood Cancers
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Jul 2014
Salix and Pharming Announce FDA Approval of RUCONEST(R) for the Treatment of Acute Angioedema Attacks in Patients with Hereditary Angioedema (HAE)
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Jun 2014
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment due to Diabetic Macular Edema in the European Union
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 27 Jun 2014
Protalix Announces New Data on ELELYSO(TM) (taliglucerase alfa) Presented at the European Working Group on Gaucher Disease 2014 11th Meeting
Biopharmaceuticals
 HSMN NewsFeed - 27 May 2014
Bristol-Myers Squibb and Incyte Enter Clinical Collaboration Agreement to Evaluate Combination Regimen of Two Novel Immunotherapies
Biopharmaceuticals Oncology
 HSMN NewsFeed - 29 Apr 2014
Novartis gains FDA approval for Zykadia(TM), first therapy for patients with ALK+ NSCLC previously treated with the ALK inhibitor crizotinib
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 Apr 2014
SI-BONE, Inc. Closes $33 Million Growth Capital Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 14 Apr 2014
Medicrea Announces European Launch of UNiD, the World’s First Patient-Specific Spinal Rod
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 7 Apr 2014
New Clinical Study Shows Masimo PVI(R) Helps Clinicians Optimize Fluid Administration in Patients Under Combined General and Epidural Anesthesia
Devices Monitoring
 HSMN NewsFeed - 26 Mar 2014
FDA Approves Optiguide(R) DCYL700 Fiber Optic Diffuser Series Flexible Fiber
Devices FDA
 HSMN NewsFeed - 5 Mar 2014
Genmab Announces Phase III Study of Daratumumab in Relapsed or Refractory Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Feb 2014
Seno Medical Instruments Raising $39 Million in Series C Funding Round
Devices Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 10 Feb 2014
Two-Year Results From Phase 3 VISTA Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema Show Sustained Improvement in Vision
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 27 Jan 2014
The Belmont(R) Rapid Infuser Expands Distribution to Japan
Devices Distribution
 HSMN NewsFeed - 22 Jan 2014
Covidien Receives U.S. Food and Drug Administration Clearance for LigaSure(TM) Maryland Jaw
Devices Surgery FDA
 HSMN NewsFeed - 13 Jan 2014
Covidien Announces Transactions Aimed at Emerging Markets ‘Value Segment’
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 13 Jan 2014
Preliminary Injunction Against Boston Scientific's Guidezilla(TM) Catheter Becomes Effective
Devices Interventional Litigation
 HSMN NewsFeed - 13 Jan 2014
EndoChoice Adds Board Members
Devices Personnel
 HSMN NewsFeed - 9 Jan 2014
Lion Biotechnologies Appoints James Bender, Ph.D., as Vice President, Product Development and Manufacturing
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 6 Jan 2014
SI-BONE, Inc. Announces 10,000 Procedure Milestone
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 6 Jan 2014
PIXUVRI(R) (pixantrone) Receives Positive Final Appraisal Determination from NICE
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 20 Dec 2013
Solana Surgical Receives FDA Clearance for the CrossCHECK Plating System
Devices Orthopaedic FDA
 HSMN NewsFeed - 18 Dec 2013
Regeneron Announces FDA Acceptance of EYLEA(R) (aflibercept) Injection Supplemental Biologics License Application for Review for Diabetic Macular Edema Indication
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 10 Dec 2013
Insulet Announces Commercial Agreement With Amgen
Devices Drug Delivery Endocrinology
 HSMN NewsFeed - 8 Dec 2013
Covidien Announces Definitive Agreement to Acquire Given Imaging
Devices Gastroenterology Mergers & Acquisitions
 HSMN NewsFeed - 25 Nov 2013
Cyclacel Announces Data Safety Monitoring Board Recommendation to Continue the SEAMLESS Phase 3 Trial of Sapacitabine in AML
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Nov 2013
EYLEA(R) (aflibercept) Injection Approved For The Treatment of Macular Edema Following Central Retinal Vein Occlusion In Japan
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 18 Nov 2013
CareFusion To Acquire Vital Signs Division of GE Healthcare For $500 Million
Devices Mergers & Acquisitions
 HSMN NewsFeed - 12 Nov 2013
Bayer receives approval for Eylea(R) as new drug to treat wet Age-Related Macular Degeneration Patients in Canada
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 11 Nov 2013
Shire to Acquire ViroPharma in Strategic Move to Strengthen Rare Disease Portfolio; Will Augment Already Strong Growth Prospects
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Nov 2013
Salix Pharmaceuticals to Acquire Santarus
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Nov 2013
Lion Biotechnologies Completes $23.3 Million Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Nov 2013
Supersaturated Oxygen Therapy IDE Study Results in Smaller Infarct Size for Next-Generation System
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Nov 2013
FDA Approves Gazyva (Obinutuzumab) for People With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 14 Oct 2013
Multiple New Studies Discuss Clinical Benefits of Given Imaging's PillCam(R) COLON at United European Gastroenterology Week
Devices Gastroenterology
 HSMN NewsFeed - 9 Oct 2013
Verax Biomedical Closes $12MM Funding Round
Diagnostics Venture Capital
 HSMN NewsFeed - 9 Oct 2013
Integra LifeSciences Announces Introduction of Integra(R) Hollywood(TM) NanoMetalene(TM) Interbody Device
Devices Orthopaedic Neurosurgery Product Launch FDA
 HSMN NewsFeed - 24 Sep 2013
FDA Approves Medtronic's Complete 'SE' Vascular Stent for Use in Superficial Femoral and Proximal Popliteal (Leg) Arteries
Devices Interventional FDA
 HSMN NewsFeed - 24 Sep 2013
Solana Surgical Receives FDA Clearance, Launches the FuseFORCE(TM) SuperElastic Fixation System
Devices Orthopaedic FDA Product Launch
 HSMN NewsFeed - 20 Sep 2013
Biomed Pharmaceuticals Announces Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2013
CSL Behring Announces FDA Approval of a 10 g (50 mL) Vial Size for Hizentra(R)
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Aug 2013
Ceptaris Receives FDA Approval for VALCHLOR(TM) (mechlorethamine) Gel for the Treatment of Stage IA and IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma in Patients Who Have Received Prior Skin-Directed Therapy
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Jul 2013
EYLEA(R) (aflibercept) Injection Recommended for Approval for the Treatment of Visual Impairment Due to Macular Edema Secondary to Central Retinal Vein Occlusion in Europe
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 3 Jul 2013
FDA Grants Genentech’s Obinutuzumab (GA101) Priority Review for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Jun 2013
Medtronic Issues Medical Device Notifications Regarding the SynchroMed(R) Implantable Infusion System
Devices Drug Delivery Product Recall
 HSMN NewsFeed - 11 Jun 2013
Royalty Pharma Statement Regarding Withdrawal of Elan Lawsuit
Biopharmaceuticals Mergers & Acquisitions Litigation
 HSMN NewsFeed - 30 May 2013
SIR-Spheres(R) microspheres as Effective and Safe in the Elderly as they are in Younger Patients with Colorectal Liver Metastases According to Data Released at ASCO Annual Meeting
Devices Drug Delivery Oncology
 HSMN NewsFeed - 20 May 2013
Covidien Receives FDA 510(k) Clearance for Nellcor(TM) Pulse Oximetry Motion Claims
Devices Monitoring FDA
 HSMN NewsFeed - 29 Apr 2013
UPLYSO(TM) (alfataliglicerase) Approved in Mexico and Chile for the Treatment of Gaucher Disease
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Apr 2013
Lantheus Medical Imaging Realigns Executive Leadership Team
Biopharmaceuticals Radiology Personnel
 HSMN NewsFeed - 15 Apr 2013
Covagen Names Elias Papatheodorou Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2013
Ibrutinib Receives Third Oncology Breakthrough Therapy Designation from U.S. Food and Drug Administration
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 27 Mar 2013
Elekta’s Advanced Versa HD System to Begin Treating Cancer Patients at New Swiss Radiotherapy Clinic
Devices Oncology
 HSMN NewsFeed - 19 Feb 2013
Regeneron and Bayer Initiate Phase 3 Trial of EYLEA(R) (aflibercept) Injection for the Treatment of Diabetic Macular Edema in Asia and Russia
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 6 Feb 2013
ZOLL Receives Shonin Approval from Japanese Ministry of Health, Labour and Welfare to Market Intravascular Temperature Management Technology
Devices Regulatory Distribution
 HSMN NewsFeed - 28 Jan 2013
Augmenix Receives FDA Clearance to Market Its TraceIT(TM) Tissue Marker
Devices Oncology Radiology FDA
 HSMN NewsFeed - 23 Jan 2013
IYIA Technologies Announces New Treatment Option for Foot Ulcers and Other Wounds That Won’t Heal
Devices Wound Care
 HSMN NewsFeed - 22 Jan 2013
Allergan, Inc. to Acquire MAP Pharmaceuticals, Inc.
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 22 Jan 2013
Clinical Trials Advancing Proton Therapy Research Open at the CDH Proton Center, A ProCure Center
Devices Oncology
 HSMN NewsFeed - 10 Jan 2013
New Study Shows Masimo Noninvasive & Continuous Total Hemoglobin (SpHb(R)) Monitoring Significantly Reduces Blood Transfusions and Costs in High Blood Loss Surgery
Devices Monitoring Surgery
 HSMN NewsFeed - 3 Jan 2013
Given Imaging Launches New ManoView(TM) ESO v3.0 Software
Devices Gastroenterology
 HSMN NewsFeed - 21 Dec 2012
FDA Approves Gattex(R) (teduglutide [rDNA Origin]) for Injection for the Treatment of Adult Short Bowel Syndrome
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 12 Dec 2012
Lilly Provides Update on Next Steps for Solanezumab
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Dec 2012
Diffusion Pharmaceuticals Receives FDA Orphan Designation for TSC, a First-in-Class Drug for the Treatment of Metastatic Brain Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 11 Dec 2012
Sirtex Medical Limited Launches New Global Website for SIR-Spheres(R) Microspheres - A Form of Selective Internal Radiation Therapy (SIRT) for Liver Tumours
Devices Oncology
 HSMN NewsFeed - 6 Dec 2012
EYLEA(R) (aflibercept) Submitted for EU Marketing Authorization for the Treatment of Macular Edema Following Central Retinal Vein Occlusion
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 27 Nov 2012
EYLEA(R) (aflibercept) Injection Approved for the Treatment of Wet Age-Related Macular Degeneration in Europe
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 26 Nov 2012
GE Healthcare Redefines Comfort, Confidence and Connectivity in Radiology at RSNA Conference
Devices Radiology
 HSMN NewsFeed - 9 Nov 2012
HeartSine Technologies Introduces Heart Trac AED Program Management and Medical Oversight Services Program
Devices Cardiology
 HSMN NewsFeed - 26 Oct 2012
NuVasive Announces PMA Approval of the PCM(R) Cervical Disc System
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 8 Oct 2012
AngioDynamics to Acquire Vortex Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 10 Sep 2012
Raptor Pharmaceutical Corp. Expands Senior Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Aug 2012
Sirtex Medical Inc. Expands U.S. Operations to Accommodate Increased Demand for SIR-Spheres Microspheres
Devices Oncology
 HSMN NewsFeed - 2 Aug 2012
Vascular Solutions Launches SuperCross(TM) FT Microcatheter
Devices Interventional Cardiology
 HSMN NewsFeed - 7 Jun 2012
D. Medical Signs an Additional U.S. Distribution Agreement for Spring Universal Infusion Sets
Devices Distribution
 HSMN NewsFeed - 16 May 2012
Medtronic Receives Notification That U.S. Department of Justice and U.S. Attorney’s Office Have Closed Their Investigation of Activities Relating to INFUSE(R) Bone Graft
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 15 May 2012
AXIOS(TM) Stent and Delivery System Study Demonstrates Successful Treatment of Pancreatic Pseudocysts and Acute Cholecystitis
Devices Gastroenterology
 HSMN NewsFeed - 3 May 2012
Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
Devices Regenerative Medicine Mergers & Acquisitions
 HSMN NewsFeed - 2 May 2012
Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device
Devices Interventional FDA
 HSMN NewsFeed - 1 May 2012
Pfizer And Protalix BioTherapeutics Announce FDA Approval Of ELELYSO(TM) (taliglucerase alfa) For The Treatment Of Gaucher Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Apr 2012
Nihon Kohden America Announces Telemetry and Enterprise Monitoring Partnership with Columbus Regional Hospital
Devices Monitoring
 HSMN NewsFeed - 17 Apr 2012
Given Imaging Designates Policlinico A. Gemelli, Catholic University in Rome, as First Colon Capsule Endoscopy Center of Excellence
Devices Gastroenterology
 HSMN NewsFeed - 16 Apr 2012
Spectrum Pharmaceuticals Commences Tender Offer for All Outstanding Shares of Allos Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 13 Apr 2012
BOTOX(R) Cosmetic (onabotulinumtoxinA) Celebrates 10-Year Anniversary of U.S. Food and Drug Administration Approval
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 6 Apr 2012
Arteriocyte Receives FDA Approval to Initiate Compartment Syndrome Trial for Amputation Prevention Focused on Wounded Warriors
Devices Orthopaedic FDA
 HSMN NewsFeed - 5 Apr 2012
Spectrum Pharmaceuticals to Acquire Allos Therapeutics: Acquisition Expected to Be Accretive on a Cash Basis in Q4 of 2012
Biopharmaceuticals Mergers & Acquisiitons
 HSMN NewsFeed - 19 Mar 2012
Genmab Provides Update on Ofatumumab Phase III Head to Head Study in DLBCL
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Mar 2012
CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery
Biopharmaceuticals Surgery
 HSMN NewsFeed - 12 Mar 2012
Asahi Kasei Announces Agreement to Acquire ZOLL Medical
Devices Mergers & Acquisitions
 HSMN NewsFeed - 8 Mar 2012
Regeneron and Bayer Announce Approval of EYLEA(R) (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 23 Feb 2012
Teleflex Introduces the FloCath(R) Quick™ Female Catheter and Insertion Kit
Devices
 HSMN NewsFeed - 9 Feb 2012
Orthofix International Launches Centronail Ankle Compression Nailing and Lapidus Plating Systems in the U.S.
Devices Orthopaedic
 HSMN NewsFeed - 30 Jan 2012
Cell Therapeutics Withdraws New Drug Application for Pixuvri™ and Plans to Resubmit in 2012
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Jan 2012
D. Medical Signs Fifth U.S. Distribution Agreement for Spring Universal Infusion Sets
Devices Distribution
 HSMN NewsFeed - 11 Jan 2012
Biomet Receives FDA Clearance for Two New Products: E1(R) Humeral Bearing for the Comprehensive(R) Reverse Shoulder System and the Comprehensive(R) Segmental Revision System
Devices Orthopaedic FDA
 HSMN NewsFeed - 14 Dec 2011
AngioScore Announces Successful Initiation of Enrollment in Drug-Coated AngioSculpt(R) Scoring Balloon Catheter First-in-Human Study
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Nov 2011
Dendreon Announces the Centers for Medicare and Medicaid Services (CMS) Will Now Cover Infusion Costs Associated with the Administration of PROVENGE
Biopharmaceuticals Oncology Reimbursement
 HSMN NewsFeed - 8 Nov 2011
Abbott Reports Five-Year Data for HUMIRA(R) (Adalimumab) in Ankylosing Spondylitis
Biopharmaceuticals
 HSMN NewsFeed - 28 Oct 2011
ALIMTA First Chemotherapy Approved in Europe as Continuation Maintenance Therapy for Most Common Form of Lung Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 18 Oct 2011
Halozyme Announces Positive Results from Roche's Subcutaneous Herceptin Phase 3 Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Oct 2011
FDA Approves Combivent(R) Respimat(R) (ipratropium bromide and albuterol) Inhalation Spray for the Treatment of Patients with Chronic Obstructive Pulmonary Disease
Biopharmaceuticals FDA
 HSMN NewsFeed - 6 Oct 2011
D. Medical Expands U.S. Distribution Network for Spring Universal Infusion Sets
Devices Distribution
 HSMN NewsFeed - 28 Sep 2011
Independent Radiology Assessment Panel Results Confirm Statistical Significance of Response and Progression Endpoints of Cell Therapeutics' Pixantrone PIX301 Pivotal Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Sep 2011
Aesculap, Inc. Acquires Aragon Surgical, Inc.
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 21 Sep 2011
ExAblate(R) Neuro has Been Used to treat 30 Patients with Chronic Neurological Disorders Such as Essential Tremor, Neuropathic Pain and Parkinson's Disease
Devices Neurology
 HSMN NewsFeed - 15 Sep 2011
Medtronic Announces 510(k) Clearance for the TSRH(R) Spinal System Pedicle Screw for the Treatment of Adolescent Idiopathic Scoliosis
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 12 Sep 2011
Medtronic Announces Launch of ARTISAN(TM) Space Maintenance System
Devices Orthopaedic
 HSMN NewsFeed - 8 Sep 2011
Angioslide Announces the European Launch of New 300 mm Long Device Allowing Treatment of Entire Superficial Femoral Artery(SFA) with One Device
Devices Interventional
 HSMN NewsFeed - 6 Sep 2011
FDA Clears Next-Generation Biomarker Test to Determine Likelihood of Ovarian Cancer in Women Who Present with Adnexal Mass
Diagnostics Oncology FDA
 HSMN NewsFeed - 30 Aug 2011
Progenics and Salix Announce FDA Acceptance of sNDA Filing for RELISTOR(R) in Patients with Non-Cancer Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 8 Aug 2011
Researchers Find RapidArc(R) Radiotherapy from Varian Medical Systems Can Quickly and Accurately Deliver Total Marrow Irradiation (TMI) Treatments for Patients with Blood Cancers
Devices Oncology
 HSMN NewsFeed - 2 Aug 2011
New NCCN Patient Guidelines Help Patients Navigate the Maze of Breast Cancer Treatment Options
Oncology
 HSMN NewsFeed - 22 Jul 2011
BIOTRONIK Vascular Enters U.S. with First Peripheral Stent Implant in BIOFLEX-I IDE Clinical Trial
Devices Interventional
 HSMN NewsFeed - 3 Jun 2011
Fox Chase Cancer Center Study Evaluating the Safety of Concurrent Chemotherapy and Selective Internal Radiation Therapy using SIR-Spheres(R) Microspheres Released at 2011 American Society of Clinical Oncology Annual Meeting
Devices Oncology
 HSMN NewsFeed - 9 May 2011
Yaupon Therapeutics Names Steve Tullman Chairman and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Apr 2011
Sangart Announces Closing of $50 Million Series G Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 19 Apr 2011
FDA Approves Rituxan Plus a Steroid for Use in Severe Forms of Vasculitis
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Apr 2011
Medtronic Introduces the MARROWMAX(TM) Bone Marrow Aspiration Needle Kit
Devices Orthopaedic Regenerative Medicine
 HSMN NewsFeed - 19 Apr 2011
Durata Therapeutics Initiates Phase 3 Study of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Biopharmaceuticals
 HSMN NewsFeed - 18 Apr 2011
FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 12 Apr 2011
Bone Solutions Inc. plans pivotal study of OsteoCrete(TM) for spinal fusion indication following constructive pilot study results, while preparing to launch OsteoCrete(TM) as an FDA-cleared bone void filler
Devices Orthopaedic
 HSMN NewsFeed - 21 Mar 2011
Cordis Demonstrates Commitment to Advancing Therapies for Below-the-Knee Vascular Disease
Devices Interventional
 HSMN NewsFeed - 18 Mar 2011
Quest Diagnostics to Acquire Celera, Strengthening Position as World's Leading Innovator in Molecular Diagnostics and Development
Diagnostics Personalized Medicine Mergers & Acquisitions
 HSMN NewsFeed - 16 Mar 2011
MAQUET Cardiovascular Receives European CE Mark for FUSION BIOLINE Vascular Graft
Devices Regulatory
 HSMN NewsFeed - 28 Feb 2011
Santarus and Pharming Announce Receipt of FDA Refusal to File Letter for RHUCIN Biologics License Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Feb 2011
Medtronic Announces Purchase of Innovative Gel Technology for Potential Use in Functional Endoscopic Sinus Surgery (FESS)
Devices Surgery Acquisitions
 HSMN NewsFeed - 22 Feb 2011
Delcath Systems Receives Refusal to File Letter From FDA
Devices Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 8 Feb 2011
Given Imaging's PillCam(R) COLON Now Reimbursable for Hospital Inpatient Use in Germany
Devices Gastroenterology Reimbursement
 HSMN NewsFeed - 7 Feb 2011
Danaher to Acquire Beckman Coulter, Inc.
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 2 Feb 2011
Lilly, Bristol-Myers Squibb Stop Enrollment in One of Two Phase III Lung Cancer Trials of Necitumumab
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Feb 2011
Omeros Announces Eligibility of OMS103HP for EMA Centralized Marketing Application
Biopharmaceuticals Orthopaedic Regulatory
 HSMN NewsFeed - 15 Dec 2010
Pfizer Extends Tender Offer To Acquire King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 Dec 2010
Accomplished U.S. Diabetes Industry Veteran, Zoe H. Myers, Joins D. Medical as Chief Commercial Officer
Devices Endocrinology Personnel
 HSMN NewsFeed - 6 Dec 2010
Sangart, Inc. Announces Cooperative Research and Development Agreement With the U.S. Navy to Evaluate MP4 Molecule in Traumatic Brain Injury
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Dec 2010
Medtronic Announces CD HORIZON(R) System 510k Pedicle Screw Clearance for Adolescent Idiopathic Scoliosis
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 2 Dec 2010
SUTENT(R) Receives European Approval for a New Indication in Progressive Pancreatic Neuroendocrine Tumors (NET)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 22 Nov 2010
Pfizer Extends Tender Offer to Acquire King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Oct 2010
OrSense Continuous Non Invasive Hemoglobin Monitoring System Demonstrates Accurate Performance During Hemorrhage Conditions
Devices Monitoring
 HSMN NewsFeed - 15 Oct 2010
FDA Approves H.P. Acthar(R) Gel for the Treatment of Infantile Spasms
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 12 Oct 2010
Pfizer to Acquire King Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Oct 2010
Phase III Novartis Data Show Potential Benefit of Afinitor(R) Plus Sandostatin(R) LAR Depot in Patients with Advanced Carcinoid Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Oct 2010
Bristol-Myers Squibb Completes Tender Offer for ZymoGenetics, Inc. with 94.9% of Shares Tendered
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Oct 2010
Integra LifeSciences Features the Integra(TM) Total Wrist Fusion System at the 65th Annual ASSH Meeting
Devices Orthopaedic
 HSMN NewsFeed - 7 Oct 2010
Privigen(R) Demonstrates Efficacy and Tolerability Among Patients With Various Immunodeficiencies, Data Show
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2010
Data Support Hizentra(R) Efficacy, Safety After Dose-Equivalent Switch in Adult and Pediatric Patients with Primary Immunodeficiency
Biopharmaceuticals
 HSMN NewsFeed - 7 Oct 2010
Study Demonstrates Safety and Efficacy of Subcutaneous Vivaglobin(R) as First-Line Therapy for Primary Immunodeficiency
Biopharmaceuticals
 HSMN NewsFeed - 6 Oct 2010
Integra LifeSciences Receives FDA Clearance for Multiple Fixation Options for Vu aPOD(TM) Prime ALIF Device
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 4 Oct 2010
Hansen Medical Announces First Patients Successfully Treated With New Flexible Catheter Vascular Robotic System
Devices Cardiology
 HSMN NewsFeed - 20 Sep 2010
Medtronic Receives FDA Approval of Integrity(R) Coronary Stent
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 10 Sep 2010
Bristol-Myers Squibb Begins Tender Offer to Acquire ZymoGenetics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Sep 2010
Bristol-Myers Squibb to Acquire ZymoGenetics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Sep 2010
La Jolla Pharmaceutical Company Provides Update on Search for Clinical Products to In-License or Acquire
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Aug 2010
Genentech Provides Update on FDA Application for T-DM1
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Aug 2010
SI-BONE, Inc. Closes $11.0 Million Financing Led by Skyline Ventures
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 17 Aug 2010
Medtronic Signs Agreement to Acquire Osteotech
Devices Regenerative Medicine Orthopaedic Acquisitions
 HSMN NewsFeed - 12 Aug 2010
FDA Grants Fenwal New 510(k) Clearance
Devices FDA
 HSMN NewsFeed - 10 Aug 2010
Urologix Announces Election of Christopher R. Barys as Director
Devices Urology Personnel
 HSMN NewsFeed - 10 Aug 2010
Labopharm announces U.S. launch of OLEPTRO(TM) for treatment of major depressive disorder in adults
Biopharmaceuticals
 HSMN NewsFeed - 27 Jul 2010
Medtronic's AMPLIFY rhBMP-2 Matrix Receives Positive Votes from FDA Advisory Panel on All Three Key Questions: Safety, Effectiveness and Benefit/Risk
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 28 Jun 2010
Bayer HealthCare Introduces First Mobile Application to Assist Hemophilia A Patients in Managing Their Treatment
Biopharmaceuticals
 HSMN NewsFeed - 22 Jun 2010
Aragon Surgical Announces Successful First Cases with the Lektrafuse CAIMAN in Bariatric Surgery
Devices Surgery
 HSMN NewsFeed - 18 Jun 2010
St. Jude Medical Announces European Approval of Industry's First Flexible Tip Ablation Catheter
Devices Cardiology Regulatory
 HSMN NewsFeed - 16 Jun 2010
Covidien Announces Definitive Agreement to Acquire Somanetics Corporation
Devices Monitoring Mergers & Acquisitions
 HSMN NewsFeed - 7 Jun 2010
Immunomedics Reports Updated Results of Targeted Therapy for Advanced Pancreatic Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Jun 2010
Covidien Announces Definitive Agreement to Acquire ev3 Inc.
Devices Mergers & Acquisitions Interventional
 HSMN NewsFeed - 26 May 2010
For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2010
Takeda to Co-Promote VELCADE(R) (bortezomib) for Injection in Japan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Mar 2010
FDA Approves Zyclara(TM) (imiquimod) Cream, 3.75% for the Treatment of Actinic Keratoses
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 24 Mar 2010
Innovative Vascular Catheterization Approach Offers New Hope
Devices Drug Delivery Interventional
 HSMN NewsFeed - 22 Mar 2010
Medtronic Announces Initial Results of STOP AF Clinical Trial
Devices Cardiology
 HSMN NewsFeed - 8 Mar 2010
Osteotech's MagniFuse(TM) Distributed to 68 U.S. Hospitals as Product Revenue Surpasses $1 Million
Regenerative Medicine
 HSMN NewsFeed - 3 Mar 2010
CaridianBCT Receives 510(k) Clearance on Latest Version of Trima Accel Automated Blood Collection System
Devices FDA
 HSMN NewsFeed - 1 Mar 2010
Baxter and ApaTech Announce Definitive Agreement
Devices Orthopaedic Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2010
Astellas Pharma Inc. Offers to Acquire OSI Pharmaceuticals for $52.00 Per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2010
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
Biopharmaceuticals
 HSMN NewsFeed - 22 Feb 2010
Memometal Technologies Acquires OrthoGlide Ankle Technology From Advanced Bio-Surfaces, Inc.
Devices Orthopaedic Acquisitions
 HSMN NewsFeed - 19 Jan 2010
Sirtex Appoints Michael Mangano to Lead U.S. Operations
Devices Oncology Personnel
 HSMN NewsFeed - 13 Jan 2010
Alphatec Spine, Inc. Enters Into Exclusive Distribution Agreement With Parcell Spine, LLC
Devices Neurosurgery Orthopaedic Licensing
 HSMN NewsFeed - 13 Jan 2010
Pathway Medical Technologies Receives FDA 510(k) Clearance for JETSTREAM G3 Atherectomy System
Devices Interventional FDA
 HSMN NewsFeed - 11 Jan 2010
Cerner Receives FDA Clearance for Medical Device Connectivity Solution
Devices Monitoring FDA
 HSMN NewsFeed - 4 Jan 2010
FDA Approves Addition of Sustained Overall Survival Benefit to Label for VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Dec 2009
European Medicines Agency Grants Cell Therapeutics Orphan Drug Designation for Pixantrone in Diffuse Large B-Cell Lymphoma (DLBCL)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 16 Dec 2009
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 7 Dec 2009
Phase III Data Showed Rituxan Plus Chemotherapy Improved Survival in Patients With Most Common Form of Adult Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Dec 2009
VELCADE(R) (Bortezomib) for Injection Based Combinations Deliver Two-Year Overall Survival Rates of Up to 88 Percent in Patients with Previously Untreated Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Dec 2009
Nasal-Aire(R) II Petite Receives FDA 510(k) Clearance for Pediatric Use
Devices FDA
 HSMN NewsFeed - 18 Nov 2009
Wright Medical Group, Inc. Announces Initial Release of the VALOR Ankle Fusion Nail System
Devices Orthopaedic
 HSMN NewsFeed - 17 Nov 2009
Ellipse Technologies, Inc. Receives CE Mark Clearance for the MAGEC(TM) System for the treatment of Spinal Scoliosis
Devices Orthopaedic Neurosurgery Regulatory
 HSMN NewsFeed - 3 Nov 2009
Nanostart Majority-Owned MagForce Announces Successful Completion of Final Clinical Trials For Nano-Cancer(R) Therapy
Devices Oncology
 HSMN NewsFeed - 28 Oct 2009
Osteotech's MagniFuse(TM) Technology Used in First U.S. Surgery
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 26 Oct 2009
FDA Determines VYVANSE(R) was Properly Granted Five-Year Market Exclusivity
Biopharmaceuticals FDA
 HSMN NewsFeed - 21 Oct 2009
Long-Term Data Updates Show Further Extensions of Survival and Delays in Recurrence in Brain Cancer Patients Who Received DCVax(R)-Brain
Biopharmaceuticals Regenerative Medicine Oncology
 HSMN NewsFeed - 9 Oct 2009
Impliant Conducts the First Two Implantations of Its New TOPS VersaLink Spinal System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 5 Oct 2009
Baxter Announces the Commercial Launch of HYLENEX at ACEP for Use in Pediatric Rehydration
Biopharmaceuticals
 HSMN NewsFeed - 24 Sep 2009
Pfizer Launches Phase 3 Clinical Trial With Novel Alk Inhibitor In Non-Small Cell Lung Cancer Patients With Specific Gene Mutation
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Sep 2009
InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry
Devices Interventional Cardiology
 HSMN NewsFeed - 23 Sep 2009
EDAP Enhances Ablatherm-HIFU European Marketing Strategy
Devices Oncology
 HSMN NewsFeed - 18 Sep 2009
FDA Grants Priority Review Status to Supplement Containing Long-Term Survival Data for VELCADE(R) (bortezomib) for Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 17 Sep 2009
Phase III Study Showed Patients Lived Longer Without Low-Grade Lymphoma Progressing When Rituxan Was Used First-Line for Maintenance
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Sep 2009
Salix Receives FDA Marketing Approval for METOZOLV ODT (Orally Disintegrating Tablets) for Relief of Diabetic Gastroparesis and Symptomatic Documented GERD
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 3 Sep 2009
Endo Pharmaceuticals Introduces VALSTAR(TM) (Valrubicin) To Fill Unmet Need In Aggressive Form of Bladder Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Sep 2009
Dainippon Sumitomo Pharma to Acquire Sepracor for U.S. $23.00 Per Share in an All-Cash Tender Offer Valued at Approximately U.S. $2.6 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 2 Sep 2009
FDA to Review Supplement Containing Long-Term Survival Data For VELCADE(R) (bortezomib) For Injection
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Sep 2009
Potential Breakthrough Cancer Treatment Now Available From Vascular Designs
Devices Drug Delivery Oncology FDA
 HSMN NewsFeed - 17 Aug 2009
Wright Medical Group, Inc. Introduces CORETRAK Articulating External Fixator for Foot Surgery
Devices Orthopaedic Surgery
 HSMN NewsFeed - 30 Jul 2009
Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
Devices Regenerative Medicine Wound Care
 HSMN NewsFeed - 28 Jul 2009
Bristol-Myers Squibb Begins Tender Offer to Acquire Medarex, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Jul 2009
Atrium Medical Corporation Announces Release of the Interim Results of the "COCTAIL Study"
Devices Interventional Cardiology
 HSMN NewsFeed - 22 Jun 2009
NeuroTherm Completes Acquisition of the Micron Epidural Catheter
Devices Acquisitions
 HSMN NewsFeed - 19 Jun 2009
NeuroTherm Completes Acquisition of the Micron Epidural Catheter
Devices Surgery Acquisitions
 HSMN NewsFeed - 18 Jun 2009
Studies Highlight A Revolutionary New Method of Treating Post-Operative Bruising
Devices Dermatology
 HSMN NewsFeed - 9 Jun 2009
Par Pharmaceutical Begins Shipment of Generic Miacalcin(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 1 Jun 2009
FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 11 May 2009
FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 11 May 2009
Eurand Announces FDA Approval of EUR-1048 (Lamictal(R) ODT(TM)), Co-Developed With GlaxoSmithKline
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Apr 2009
Immunomedics Reports Results That Could Expand Use of Milatuzumab in Cancer Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Apr 2009
Apidra(R) SoloSTAR(R), the Easy-to-Use Insulin Delivery Device from sanofi-aventis, Now Available in the United States
Devices Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 31 Mar 2009
New Clinical Study Shows Masimo PVI(TM) Accurately Predicts Fluid Responsiveness in the ICU
Devices Monitoring
 HSMN NewsFeed - 23 Mar 2009
IlluminOss(TM) Photodynamic Bone Stabilization System Receives CE Mark
Devices Orthopaedic Regulatory
 HSMN NewsFeed - 23 Mar 2009
U.S. FDA Approves New THERAKOS(TM) CELLEX(TM) Photopheresis System
Devices Oncology FDA
 HSMN NewsFeed - 17 Mar 2009
Flexible Stenting Solutions, Inc. Announces IDE Submission for FlexStent(R) Femoropopliteal Self Expanding Stent System
Devices Interventional FDA
 HSMN NewsFeed - 16 Mar 2009
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
Biopharmaceuticals
 HSMN NewsFeed - 11 Mar 2009
Phase III Study of Rituxan in Lupus Nephritis Did Not Meet Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2009
FDA Approves Apidra(R) SoloSTAR(R) - a Prefilled Disposable Insulin Pen
Biopharmaceuticals Drug Delivery Endocrinology FDA
 HSMN NewsFeed - 23 Feb 2009
Alphatec Spine Licenses New Technology to Treat Lumbar Spinal Stenosis
Devices Neurosurgery Orthopaedic Licensing
 HSMN NewsFeed - 23 Feb 2009
Genentech Special Committee Rejects Roche's $86.50 Offer as Inadequate
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Feb 2009
GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 17 Feb 2009
Bard Receives FDA Approval for the LifeStent Vascular Stent
Devices Interventional FDA
 HSMN NewsFeed - 17 Feb 2009
Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Feb 2009
Physicians Continue to Limit Sales Rep Access
Biopharmaceuticals Devices
 HSMN NewsFeed - 29 Jan 2009
Immunomedics Reports Properties and Structure-Function Relationships of Veltuzumab
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Jan 2009
Astellas Proposes to Acquire CV Therapeutics for $16 per Share in Cash
Biopharmaceuticals Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 16 Jan 2009
New Overall Survival Study Results Confirm Oral Xeloda(R) plus Oxaliplatin (XELOX) is Comparable to FOLFOX-4 for the First-Line Treatment of Advanced Colorectal Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Jan 2009
New Smart Toe Implant Lets Foot Surgery Patients Go 'Wireless'
Devices Orthopaedic
 HSMN NewsFeed - 16 Dec 2008
Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
Diagnostics Oncology Licensing
 HSMN NewsFeed - 8 Dec 2008
MGuard(TM) Coronary Stent System Approved in Israel
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 6 Dec 2008
Rituxan in Combination with Chemotherapy Improves Progression-Free Survival in Difficult-to-Treat Form of Blood Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 4 Dec 2008
Broncus Technologies Secures $38 Million in Funding Round Led by Ares Life Sciences
Devices Venture Capital
 HSMN NewsFeed - 3 Dec 2008
MEDTRONIC STATEMENT
Devices
 HSMN NewsFeed - 24 Nov 2008
Biovitrum's and Syntonix's Novel Factor IXFc for Hemophilia B has Received Orphan Drug Designation From the FDA
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Oct 2008
New Study Shows ENBREL(R) (etanercept) Is More Effective than a DMARD in the Treatment of Symptoms of Ankylosing Spondylitis Patients
Biopharmaceuticals
 HSMN NewsFeed - 16 Oct 2008
Pioneer(R) Surgical Technology Announces First Human Implants of New nanOss(TM)-Cervical Fusion Device
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 16 Oct 2008
Micronics Completes Series C Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 14 Oct 2008
Baxa Ltd Launches ZR(R) Pre-Filled Saline Flush Syringes
Devices
 HSMN NewsFeed - 8 Oct 2008
Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 7 Oct 2008
Alphatec Spine Launches New Orthobiologics Product - ProFUSE Bone Scaffold Packaged in Proprietary Vacuum Infusion Packaging System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 29 Sep 2008
Pioneer(R) Surgical Technology Announces the Market Release of its Cross-Fuse(TM) Lateral Vertebral Body Replacement (VBR) System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 25 Sep 2008
Alphatec Spine Announces 510(k) Clearance for Its Novel Cervical Interbody Implant
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 3 Sep 2008
Pioneer(R) Surgical Technology Receives 510(k) Clearance to Market FortrOss(TM), A Next Generation Bone Void Filler
Devices Orthopaedic FDA
 HSMN NewsFeed - 3 Sep 2008
Neurotech Granted Fast Track Designations from the FDA for NT-501 in Two Indications - Retinitis Pigmentosa and Dry Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 2 Sep 2008
Introgen Receives Notice ADVEXIN(R) U.S. BLA Not Sufficiently Complete to File
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Aug 2008
New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 Aug 2008
Ikaria(R) Strengthens Commercial Operations and Human Resources Leadership
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2008
Emerging Clinical Data Continues to Support CyberKnife Radiosurgery for the Treatment of Lung Cancer
Devices Oncology
 HSMN NewsFeed - 31 Jul 2008
Genmab and GlaxoSmithKline Announce Positive Top-Line Results in Ofatumumab Chronic Lymphocytic Leukemia Pivotal Study
Biopharmaceuticals Oncology
 HSMN NewsFeed - 23 Jul 2008
Pioneer(R) Surgical Technology, Inc. Announces the Market Launch of the SlimFuse(TM) Anterior Cervical Plate System
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 18 Jul 2008
minSURG(TM) Corporation Launches International Division
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 17 Jul 2008
Impliant Launches Less-Invasive Version of Patented TOPS(TM) Spine System
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 10 Jul 2008
AngioScore Launches New Longer and Larger AngioSculpt(R) Devices for Treatment of Peripheral Artery Disease
Devices Interventional
 HSMN NewsFeed - 26 Jun 2008
Integra LifeSciences Announces the Launch of the Tibiaxys Plating System
Devices Orthopaedic
 HSMN NewsFeed - 24 Jun 2008
Six Weeks of Radiation Therapy May Be Unnecessary for Many Breast Cancer Patients
Devices Oncology
 HSMN NewsFeed - 13 Jun 2008
Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
Biopharmaceuticals
 HSMN NewsFeed - 9 Jun 2008
Curlin Medical Awarded Three-Year Pain Management - Local Anesthetic Contract by Premier, Inc.
Devices Drug Delivery Group Purchasing
 HSMN NewsFeed - 9 Jun 2008
Sequential R-CHOP and Ibritumomab Tiuxetan (Zevalin(R)) Regimen Produces Impressive Survival Rates in High Risk Elderly Patients With Untreated Aggressive Diffuse Large B-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 31 May 2008
VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 28 May 2008
Taro Terminates Merger Agreement with Sun Pharmaceutical Industries Ltd.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 May 2008
Impliant Restarts Pivotal Clinical Trial for Patented TOPS(TM) Spine System
Devices Orthopaedic
 HSMN NewsFeed - 22 May 2008
Pioneer(R) Surgical Technology Introduces the BacJac(TM) Interspinous Decompression System to the European Spine Market
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 21 May 2008
Sirtex Launches Global Clinical Trial Comparing the Use of SIR-Spheres(R) Microspheres Plus Chemotherapy versus Chemotherapy Alone as First Line Treatment for Metastatic Colorectal Cancer
Devices Oncology
 HSMN NewsFeed - 20 May 2008
Elesclomol Study Shows Significant Improvement in Progression-Free Survival for Chemotherapy-Naive Patients With Metastatic Melanoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 May 2008
Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2008
Sirtex Sponsors Pilot Study Evaluating SIR-Spheres(R) Microspheres for the Treatment of Unresectable Hepatocelluar Carcinoma
Devices Interventional Oncology
 HSMN NewsFeed - 13 May 2008
Siemens Introduces Dual Energy Applications for General Imaging
Devices Radiology
 HSMN NewsFeed - 13 May 2008
FDA Approves NOVO NORDISK's NovoSeven(R) RT (Coagulation Factor VIIa [Recombinant] Room Temperature Stable) for Hemophilia Patients With Inhibitors
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2008
Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 May 2008
Cordis Corporation Launches New Peripheral Angioplasty Balloon Catheters
Devices Interventional
 HSMN NewsFeed - 2 May 2008
Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device
Devices Orthopaedic Neurosugery
 HSMN NewsFeed - 29 Apr 2008
Medtronic Receives Approval to Market Smaller Kit Sizes of INFUSE(R) Bone Graft
Devices Orthopaedic FDA
 HSMN NewsFeed - 29 Apr 2008
Genentech and Biogen Idec Announce Top-Line Results from Phase II/III Clinical Study of Rituxan in Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 29 Apr 2008
Takeda and Millennium Announce Early Termination of Hart-Scott-Rodino Waiting Period
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Apr 2008
Arch Therapeutics Licenses Groundbreaking Intellectual Property on Hemostasis
Biopharmaceuticals Surgery Licensing
 HSMN NewsFeed - 16 Apr 2008
Graceway Pharmaceuticals Reports Study in British Journal of Dermatology: Patients Treated with ALDARA Experienced Higher Levels of Histological and Sustained Clearance for Actinic Keratosis (AK) than Patients in two Other Common AK Treatments
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 15 Apr 2008
Cardium's Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
Devices Cardiology
 HSMN NewsFeed - 10 Apr 2008
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Apr 2008
Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Apr 2008
Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 25 Mar 2008
Pioneer(R) Surgical Technology Receives 510(k) Clearance to Market Next Generation Pedicle Screw System
Devices Neurosurgery Orthopaedic FDA
 HSMN NewsFeed - 25 Mar 2008
Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Mar 2008
Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
Biopharmaceuticals Oncology
 HSMN NewsFeed - 24 Mar 2008
Sirtex Announces New President for U.S. Operations
Devices Personnel
 HSMN NewsFeed - 13 Mar 2008
Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Mar 2008
Siemens Introduces New Dual Energy Applications to SOMATOM Definition
Devices Radiology
 HSMN NewsFeed - 5 Mar 2008
CHOP-Zevalin(R) Investigational Regimen Produces 95% Complete Remission and 75% Estimated Two Year Progression-Free Survival in Elderly Patients with Diffuse Large B-cell Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Mar 2008
AEterna Zentaris and Paladin Labs Announce Sale and Purchase of Miltefosine Rights
Biopharmaceutical Acquisitions
 HSMN NewsFeed - 22 Feb 2008
Adherex Receives Orphan Drug Designation for ADH-1 in Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Feb 2008
Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Feb 2008
YM Biosciences USA Enrolls First Patient in Phase II Trial of Nimotuzumab in Children with Inoperable, Recurrent Brain Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Jan 2008
FDA Grants Priority Review For Velcade(R) (bortezomib) for Injection In Patients with Newly Diagnosed Multiple Myeloma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 28 Jan 2008
MicroIslet Announces the Appointments of Dr. Chris Marsh as Lead Transplant Advisor, and Dr. Ronald Goldblum as Lead Clinical Development Consultant
Regenerative Medicine Personnel
 HSMN NewsFeed - 17 Jan 2008
Zevalin(R) Combined With High-Dose Chemotherapy and Autologous Stem-Cell Transplantation (ASCT) Produces High Overall Survival and Progression-Free Survival Rates in Patients With Relapsed Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 Jan 2008
RSB Spine, LLC Announces First Implantation of the InterPlate(TM) L for the Lumbar Spine
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 16 Jan 2008
St. Jude Medical Announces U.S. Clearance for Cardiac Image Integration Software
Devices Cardiology FDA
 HSMN NewsFeed - 8 Jan 2008
Halozyme Therapeutics Announces Peer-Reviewed Publications of the INFUSE-LR Clinical Trial Results and Clinical Practice Experience With Hylenex
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2008
Xeloda(R) Combination Therapy in Esophagogastric Cancer Highlighted in New England Journal of Medicine
Biopharmaceuticals Oncology
 HSMN NewsFeed - 2 Jan 2008
Echo Therapeutics Starts Clinical Study of Its Symphony(TM) Continuous Transdermal Glucose Monitoring System
Devices Monitoring
 HSMN NewsFeed - 27 Dec 2007
Cell Therapeutics, Inc. (CTI) Completes Acquisition of Lymphoma Drug Zevalin(R) From Biogen Idec for Sales and Marketing in the United States
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 21 Dec 2007
Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma
Biopharmaceuticals FDA Oncology
 HSMN NewsFeed - 20 Dec 2007
DRAXIS Names GE Healthcare as Exclusive Distributor of DRAXIMAGE(R) Sestamibi in USA
Biopharmaceuticals Radiology Distribution
 HSMN NewsFeed - 12 Dec 2007
Once-Daily Exjade(R) Shown to Remove Toxic Iron From the Heart and Liver, According to Data Presented at ASH
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2007
PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
Biopharmaceuticals
 HSMN NewsFeed - 10 Dec 2007
VELCADE(R) (Bortezomib) for Injection Based Therapy Produced Significant Complete Remission Rates Pre- and Post-Transplantation in IFM Phase III Front-Line Multiple Myeloma Trial
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Dec 2007
Epratuzmab Plus Rituximab Produce Durable Complete Responses in Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 10 Dec 2007
Eisai to Acquire MGI PHARMA for $41 Per Share in an All Cash Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Dec 2007
Phase III Trial of VELCADE(R) (Bortezomib) for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates When Combined With the Most Commonly Used U.S. Regimen in Front-Line Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Dec 2007
Highest Reported Complete Remission Rate of 35 Percent Achieved in a Phase III Front-Line Multiple Myeloma Trial With Velcade(R) (Bortezomib) for Injection Based Therapy
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Dec 2007
Baxa Corporation Launches MedBoard(TM) Medication Tracking System
Devices
 HSMN NewsFeed - 3 Dec 2007
Baxa Corporation Launches Repeater(TM) Pump II With P2(TM) Technology
Devices
 HSMN NewsFeed - 3 Dec 2007
Eurand Acquires Specialty Cystic Fibrosis Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Nov 2007
New Data to Support VELCADE(R) (Bortezomib) For Injection Based Therapies as Setting New Standards in The Care of Newly Diagnosed Patients With Multiple Myeloma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 26 Nov 2007
Cytheris Appoints Richard Keatinge as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2007
High-price Vaccines Spark Four-fold Growth in Pediatric & Adolescent Vaccines Market
Biopharmaceuticals
 HSMN NewsFeed - 13 Nov 2007
Cardiogenesis Receives FDA Approval for PEARL 5.0 Robotic Hand Piece
Devices Cardiology FDA
Return to NewsFeed  

 Additional items found! 366

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 366 additional stories matching:
Fuse
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.